Kenneth W. Duncan,Richard Chesworth,Paula Ann Boriack-Sjodin,Michael John Munchhof,Lei Jin
申请号：
US15844097
公开号：
US10391089B2
申请日:
2017.12.15
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
